MD Anderson Researchers Present Immunotherapy Advances at Society for Immunotherapy of Cancer Annual Meeting
November 12, 2020
November 12, 2020
HOUSTON, Texas, Nov. 12 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) .
&qu . . .
Promising clinical results with combination treatments for patients with melanoma and lung cancer highlight immunotherapy advances being presented by researchers from The University of Texas MD Anderson Cancer Center at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) .
&qu . . .